Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 16, 2022

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2028

Conditions
Waldenstrom's DiseaseWaldenstrom Macroglobulinemia
Interventions
BIOLOGICAL

bone marrow sample

8 to 13 ml bone marrow sample for frozen storage within one of the 5 certified biobank of the canceropole area.

BIOLOGICAL

blood sample

20 ml blood sample for frozen storage within one of the 5 certified biobank of the canceropole area.

Trial Locations (1)

80480

RECRUITING

CHU Amiens, Amiens

All Listed Sponsors
collaborator

Centre Henri Becquerel

OTHER

collaborator

University Hospital, Caen

OTHER

collaborator

University Hospital, Lille

OTHER

collaborator

Centre Hospitalier de Lens

OTHER

lead

Centre Hospitalier Universitaire, Amiens

OTHER